Ha, good questions and observations about Pestell.
Post# of 148265
https://www.cytodyn.com/newsroom/press-releas...ith-former
Quote:
Dr. Pestell and the Company are also exploring ways in which Dr. Pestell can reengage with the Company to help realize leronlimab’s full potential in oncology.
I really don't know his current role, just speculating about why cancer is back on the table for trials, and why CRC versus TNBC, GBM, prostate, or other cancer.